In 2008, the quality of blood thinning products produced by Baxter was brought into question when they were linked to 19 deaths in the United States.<ref name=time1>{{cite news |title=Heparin's Deadly Side Effects |url=http://www.time.com/time/magazine/article/0,9171,1858870,00.html |work=Time magazine |access-date=November 16, 2008 |date=November 13, 2008 |archiveurl=https://web.archive.org/web/20081121194220/http://www.time.com/time/magazine/article/0%2C9171%2C1858870%2C00.html |archivedate=November 21, 2008 |deadurl=no |df=mdy-all }}</ref> Upon inspection, one of the raw ingredients used by Baxter was found to be contaminated – between 5 and 20 percent – with a substance that was similar, but not identical, to the ingredient itself. The company initiated a voluntary recall, temporarily suspended the manufacture of [[heparin]], and launched an investigation.
